Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tierra Biosciences is a synthetic biology company that has developed a high-throughput, cell-free protein synthesis platform. The company's technology, known as the Tierra Protein Platform, allows researchers to move from digital DNA sequences to purified proteins in a matter of weeks, significantly faster than traditional cell-based methods. By leveraging automation and machine learning, Tierra provides custom protein synthesis services that support the discovery and development of new therapeutics, industrial enzymes, and bio-based materials. The company serves a diverse range of clients across the pharmaceutical, biotechnology, and agricultural sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tierra Group.